Loading...
Restoration of defective cross-presentation in tumors by gemcitabine
Tumor antigen cross-presentation by dendritic cells (DCs) to specific CD8(+) T cells is central to antitumor immunity. Although highly efficient in draining lymph nodes, it is defective within the tumor site itself. Importantly, an immunogenic chemotherapy, gemcitabine, reverses this defect, allowin...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485774/ https://ncbi.nlm.nih.gov/pubmed/26155402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1005501 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|